163 related articles for article (PubMed ID: 23909434)
1. Systematic review about breast cancer incidence in relation to hormone replacement therapy use.
Antoine C; Ameye L; Paesmans M; Rozenberg S
Climacteric; 2014 Apr; 17(2):116-32. PubMed ID: 23909434
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer.
Lancet; 1997 Oct; 350(9084):1047-59. PubMed ID: 10213546
[TBL] [Abstract][Full Text] [Related]
3. Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe.
Stahlberg C; Pedersen AT; Lynge E; Andersen ZJ; Keiding N; Hundrup YA; Obel EB; Ottesen B
Int J Cancer; 2004 May; 109(5):721-7. PubMed ID: 14999781
[TBL] [Abstract][Full Text] [Related]
4. Update of the evolution of breast cancer incidence in relation to hormone replacement therapy use in Belgium.
Antoine C; Ameye L; Paesmans M; Rozenberg S
Maturitas; 2012 Aug; 72(4):317-23. PubMed ID: 22627077
[TBL] [Abstract][Full Text] [Related]
5. The incidence of breast cancer and changes in the use of hormone replacement therapy: a review of the evidence.
Verkooijen HM; Bouchardy C; Vinh-Hung V; Rapiti E; Hartman M
Maturitas; 2009 Oct; 64(2):80-5. PubMed ID: 19709827
[TBL] [Abstract][Full Text] [Related]
6. Changes by age in breast cancer incidence, mammography screening and hormone therapy use in France from 2000 to 2006.
Séradour B; Allemand H; Weill A; Ricordeau P
Bull Cancer; 2009 Apr; 96(4):E1-6. PubMed ID: 19435691
[TBL] [Abstract][Full Text] [Related]
7. [Effects of hormone replacement therapy for menopause on prognostic factors of breast cancer].
Bonnier P; Sakr R; Bessenay F; Lejeune C; Charpin C; Martin PM; Piana L
Gynecol Obstet Fertil; 2000 Oct; 28(10):745-53. PubMed ID: 11244637
[TBL] [Abstract][Full Text] [Related]
8. Declining incidence of breast cancer after decreased use of hormone-replacement therapy: magnitude and time lags in different countries.
Zbuk K; Anand SS
J Epidemiol Community Health; 2012 Jan; 66(1):1-7. PubMed ID: 21875869
[TBL] [Abstract][Full Text] [Related]
9. Does hormone replacement therapy (HRT) cause breast cancer? An application of causal principles to three studies.
Shapiro S; Farmer RD; Stevenson JC; Burger HG; Mueck AO; Gompel A
J Fam Plann Reprod Health Care; 2013 Apr; 39(2):80-8. PubMed ID: 23493592
[TBL] [Abstract][Full Text] [Related]
10. The Risk of Breast Cancer in Women Using Menopausal Hormone Replacement Therapy in Taiwan.
Liu JY; Chen TJ; Hwang SJ
Int J Environ Res Public Health; 2016 May; 13(5):. PubMed ID: 27187426
[TBL] [Abstract][Full Text] [Related]
11. Reductions in use of hormone replacement therapy: effects on Swedish breast cancer incidence trends only seen after several years.
Lambe M; Wigertz A; Holmqvist M; Adolfsson J; Bardage C; Fornander T; Karlsson P; Odlind V; Persson I; Ahlgren J; Bergkvist L
Breast Cancer Res Treat; 2010 Jun; 121(3):679-83. PubMed ID: 19894110
[TBL] [Abstract][Full Text] [Related]
12. Hormone use for menopausal symptoms and risk of breast cancer. A Danish cohort study.
Ewertz M; Mellemkjaer L; Poulsen AH; Friis S; Sørensen HT; Pedersen L; McLaughlin JK; Olsen JH
Br J Cancer; 2005 Apr; 92(7):1293-7. PubMed ID: 15785751
[TBL] [Abstract][Full Text] [Related]
13. Evolution of breast cancer incidence in relation to hormone replacement therapy use in Belgium.
Antoine C; Ameye L; Moreau M; Paesmans M; Rozenberg S
Climacteric; 2011 Aug; 14(4):464-71. PubMed ID: 21545271
[TBL] [Abstract][Full Text] [Related]
14. Effects of estrogens and hormone replacement therapy on breast cancer risk and on efficacy of breast cancer therapies.
Verheul HA; Coelingh-Bennink HJ; Kenemans P; Atsma WJ; Burger CW; Eden JA; Hammar M; Marsden J; Purdie DW
Maturitas; 2000 Jul; 36(1):1-17. PubMed ID: 10989237
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort.
Fournier A; Berrino F; Riboli E; Avenel V; Clavel-Chapelon F
Int J Cancer; 2005 Apr; 114(3):448-54. PubMed ID: 15551359
[TBL] [Abstract][Full Text] [Related]
16. Hormone replacement therapy and breast cancer risk in California.
Coombs NJ; Taylor R; Wilcken N; Fiorica J; Boyages J
Breast J; 2005; 11(6):410-5. PubMed ID: 16297085
[TBL] [Abstract][Full Text] [Related]
17. Hormone replacement therapy and the sensitivity and specificity of breast cancer screening: a review.
Banks E
J Med Screen; 2001; 8(1):29-34. PubMed ID: 11373847
[TBL] [Abstract][Full Text] [Related]
18. Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality.
O'Meara ES; Rossing MA; Daling JR; Elmore JG; Barlow WE; Weiss NS
J Natl Cancer Inst; 2001 May; 93(10):754-62. PubMed ID: 11353785
[TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
20. Do women taking hormone replacement therapy (HRT) have a higher incidence of breast cancer than women who do not?
Fleming RM
Integr Cancer Ther; 2003 Sep; 2(3):235-7. PubMed ID: 15035886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
